Efficacy of Trans Abdominis Plane Block for Post Cesarean Delivery Analgesia

NCT ID: NCT06556381

Last Updated: 2024-08-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-04-01

Study Completion Date

2024-08-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Relief from pain is part of the fundamental human right to health. (1) However, available evidence indicates an increasingly detailed understanding of the pathophysiology of pain and general inadequacy of its treatment.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Background: Relief from pain is part of the fundamental human right to health. (1) However, available evidence indicates an increasingly detailed understanding of the pathophysiology of pain and general inadequacy of its treatment.

Rationale: Assessment and Improving the Pain Management Modality

Study objectives: In this study, determined the efficacy of TAP block in patients undergoing cesarean section.

Methods:

This study is a cross-sectional study. It is a multi-centric study as it was conducted in different Governmental hospitals.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Analgesia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group A,

women who received TAP block.

Group Type EXPERIMENTAL

TAP block

Intervention Type PROCEDURE

Women will receive TAP block.

Group B

Received Usual modality of analgesics (Paracetamol, Tramadol, and Pethidine).

Group Type ACTIVE_COMPARATOR

TAP block

Intervention Type PROCEDURE

Women will receive TAP block.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

TAP block

Women will receive TAP block.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Age: 20-50 years
2. Patients of \>50 kg or \<100 kg weight.
3. Urgency: Elective, Emergent and Urgent cases

Exclusion Criteria

1. Patients of \<50 kg or \>100 kg weight
2. Any contraindication to any of anesthesia medications
3. Patient unable to understand numeric rating scale (NRS)
Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Qassim University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mohammed Abaalkhayl

Associate Proffesor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mohammed Abaalkhayl, MD

Role: PRINCIPAL_INVESTIGATOR

Qassim University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Qassim University Medical City

Buraidah, Al-Qassim Region, Saudi Arabia

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Saudi Arabia

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

HANI ALNAJJAR, BSN

Role: CONTACT

00966553873999

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Mohammed Abaalkhayl, MD

Role: primary

HANI ALNAJJAR, BSN

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

607/46/828

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Effect of TAP Block on Stress Hormones
NCT03443271 COMPLETED PHASE4